NxThera
company
About
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Health Care,Medical,Medical Device
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
NxThera develops medical technologies to treat a variety of endourology conditions, including BPH. The company's technology platform utilizes a simple, minimally invasive, vapor therapy designed to measurably improve urinary flow and patient quality of life. BPH afflicts more than 32 million men in the United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
NxThera has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Dec 3, 2015 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 3, 2015 | Series D | $40M | 1 |
Boston Scientific
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
NxThera is funded by 1 investors.
Boston Scientific
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boston Scientific
|
Yes | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
